Charco Neurotech is developing a novel wearable device to aid people with Parkinson’s disease in managing their movement symptoms. The company’s flagship product, CUE1, is a small disc-like gadget that delivers focused vibrotactile stimulation to the chest, which has shown in trials to smooth out stiffness and slowness in Parkinson’s patients’ movements. The CUE1 device is worn externally (often on the sternum) and emits gentle vibrations at specific frequencies.

This neuromodulatory cue is believed to entrain neural circuits involved in motor control, helping to overcome bradykinesia and freezing. The device is non-invasive and activated on demand with a simple button press, making it easy for patients to use in daily life. Charco’s approach leverages the phenomenon of sensory stimulation improving motor output (similar to rhythmic cueing) and is drug-free. CUE1 is intended for individuals with Parkinson’s disease to improve gait and mobility.

By providing continuous or on-demand vibration therapy, users report smoother, more coordinated movements and better balance when the device is on. This can translate to improved ability in walking, writing, or other activities that are hampered by rigidity and tremor. The non-pharmaceutical nature of the device means it can complement medications, and its ease of use allows it to be integrated into everyday routines. Charco Neurotech’s innovation thus offers a portable neuromodulation option to enhance quality of life for the aging population dealing with Parkinson’s, highlighting how wearable tech can assist in neurological rehabilitation.